80 FR 32385 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention Federal Register Volume 80, Issue 109 (June 8, 2015)
Centers for Disease Control and Prevention
Federal Register Volume 80, Issue 109 (June 8, 2015)
| Page Range | 32385-32385 | |
| FR Document | 2015-13924 |
[Federal Register Volume 80, Number 109 (Monday, June 8, 2015)] [Notices] [Page 32385] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2015-13924] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA), CK15-004, Epicenters for the Prevention of Healthcare Associated Infections (HAIs)--Cycle II. Time and Date: 10:00 a.m.-4:00 p.m., EDT, July 9, 2015 (Closed). Place: Teleconference. Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463. Matters for Discussion: The meeting will include the initial review, discussion, and evaluation of applications received in response to ``Epicenters for the Prevention of Healthcare Associated Infections (HAIs)--Cycle II'', FOA CK15-004. Contact Person for More Information: Gregory Anderson, M.S., M.P.H., Scientific Review Officer, CDC, 1600 Clifton Road NE., Mailstop E60, Atlanta, Georgia 30329-4027, Telephone: (404) 718- 8833. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 2015-13924 Filed 6-5-15; 8:45 am] BILLING CODE 4163-18-P
![Federal Register / Vol. 80, No. 109 / Monday, June 8, 2015 / Notices 32385
ESTIMATED ANNUALIZED BURDEN HOURS
Number of Average Total
Number of responses burden per
Type of respondents Form name burden
respondents per response (in hrs.)
respondent (in hrs.)
Quitline callers who contact the NQDW Intake Questionnaire (complete) .............. 509,742 1 10/60 84,957
quitline for help themselves.
Caller who contacts the quitline on NQDW Intake Questionnaire (subset) .................. 26,902 1 1/60 448
behalf of someone else.
Quitline caller who received a quitline NQDW 7-Month Follow-Up Questionnaire ............ 659 1 7/60 77
service from the Asian Smokers’
quitline.
Tobacco Control Manager or Their Instructions for Submitting NQDW Intake Ques- 54 4 1 216
Designee. tionnaire Electronic Data File to CDC. 1 1 1 1
Instructions for Submitting NQDW 7-Month Fol-
low-up Electronic Data File to CDC.
NQDW Quitline Services Survey .......................... 54 4 20/60 72
Total ............................................ ................................................................................ .................... .................... .................... 85,771
Leroy A. Richardson, The Director, Management Analysis and the event by Friday, July 3, 2015, at the
Chief, Information Collection Review Office, Services Office, has been delegated the following link: http://www.cdc.gov/tribal/
Office of Scientific Integrity, Office of the authority to sign Federal Register notices meetings.html.
Associate Director for Science, Office of the pertaining to announcements of meetings and Purpose: The purpose of these recurring
Director, Centers for Disease Control and other committee management activities, for meetings is to advance CDC/ATSDR support
Prevention. both the Centers for Disease Control and for and collaboration with tribes, and to
Prevention and the Agency for Toxic improve the health of tribes through,
[FR Doc. 2015–13849 Filed 6–5–15; 8:45 am]
Substances and Disease Registry. including but not limited to, assisting in
BILLING CODE 4163–18–P eliminating the health disparities faced by
Elaine L. Baker, Indian tribes, ensuring that access to critical
Director, Management Analysis and Services health and human services and public health
DEPARTMENT OF HEALTH AND Office, Centers for Disease Control and services is maximized to advance or enhance
HUMAN SERVICES Prevention. the social, physical, and economic status of
[FR Doc. 2015–13924 Filed 6–5–15; 8:45 am] American Indian/Alaska Native (AI/AN)
Centers for Disease Control and BILLING CODE 4163–18–P people; and promoting health equity for all
Prevention AI/AN people and communities. To advance
these goals, CDC/ATSDR conducts
Disease, Disability, and Injury government-to-government consultations
DEPARTMENT OF HEALTH AND
Prevention and Control Special with elected tribal officials or their
HUMAN SERVICES authorized representatives. Consultation is
Emphasis Panel (SEP): Initial Review an enhanced form of communication that
Centers for Disease Control and emphasizes trust, respect, and shared
In accordance with Section 10(a)(2) of Prevention
the Federal Advisory Committee Act responsibility. It is an open and free
exchange of information and opinion among
(Pub. L. 92–463), the Centers for Disease Office for State, Tribal, Local and parties that leads to mutual understanding
Control and Prevention (CDC) Territorial Support and comprehension.
announces a meeting for the initial Matters for Discussion: The TAC and CDC
review of applications in response to In accordance with Presidential leaders will discuss the following public
Funding Opportunity Announcement Executive Order No. 13175, November health topics: Chronic disease prevention
(FOA), CK15–004, Epicenters for the 6, 2000, and the Presidential and health promotion in Indian Country,
Prevention of Healthcare Associated Memorandum of November 5, 2009, and CDC’s budget, and CDC’s communication and
Infections (HAIs)—Cycle II. September 23, 2004, Consultation and engagement with tribes; however, discussion
Coordination with Indian Tribal is not limited to these topics.
Time and Date: 10:00 a.m.–4:00 p.m., EDT, Governments, CDC/Agency for Toxic During the 13th Biannual Tribal
July 9, 2015 (Closed). Consultation Session, tribes and CDC leaders
Place: Teleconference.
Substances and Disease Registry
will engage in a listening session with CDC’s
Status: The meeting will be closed to the (ATSDR), announces the following
director and have roundtable discussions
public in accordance with provisions set meeting and Tribal Consultation with CDC senior leaders. Tribes will also
forth in Section 552b(c)(4) and (6), Title 5 Session: have an opportunity to present testimony on
U.S.C., and the Determination of the Director, Name: Tribal Advisory Committee (TAC) tribal health issues.
Management Analysis and Services Office, Meeting and 13th Biannual Tribal Tribal leaders are encouraged to submit
CDC, pursuant to Public Law 92–463. Consultation Session. written testimony by July 17, 2015, by mail
Matters for Discussion: The meeting will Times and Dates: 8:00 a.m.–5:00 p.m., to Annabelle Allison, Deputy Associate
include the initial review, discussion, and August 4, 2015 (TAC Meeting); 8:00 a.m.– Director, Tribal Support Unit, Office for
evaluation of applications received in State, Tribal, Local and Territorial Support
mstockstill on DSK4VPTVN1PROD with NOTICES
5:00 p.m., August 5, 2015 (13th Biannual
response to ‘‘Epicenters for the Prevention of Tribal Consultation Session). (OSTLTS), Centers for Disease Control and
Healthcare Associated Infections (HAIs)— Place: The TAC Meeting and Tribal Prevention, 4770 Buford Highway NE., MS
Cycle II’’, FOA CK15–004. Consultation Session will be held at the E–70, Atlanta, Georgia 30341, or by email to
Contact Person for More Information: Northern Quest, 100 North Hayford Road, TribalSupport@cdc.gov.
Gregory Anderson, M.S., M.P.H., Scientific Airway Heights, Washington 99001. Depending on the time available, it might
Review Officer, CDC, 1600 Clifton Road NE., Status: The meetings are being hosted by be necessary to limit each presenter’s time.
Mailstop E60, Atlanta, Georgia 30329–4027, CDC/ATSDR in-person only and are open to The agenda is subject to change as
Telephone: (404) 718–8833. the public. Attendees must pre-register for priorities dictate.
VerDate Sep<11>2014 17:09 Jun 05, 2015 Jkt 235001 PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 E:\FR\FM\08JNN1.SGM 08JNN1](https://thefederalregister.org/doc/80_FR_32494/page/1.svg)
Document Created: 2018-02-22 10:12:37
Document Modified: 2018-02-22 10:12:37
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Dates | 10:00 a.m.-4:00 p.m., EDT, July 9, 2015 (Closed). | |
| FR Citation | 80 FR 32385 |
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR